Login Register Cart 0
Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Retraction Notice

RETRACTED: Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery

Author(s): Da-Yong Lu*, Peng-Peng Zhu, Hong-Ying Wu, Bin Xu and Ting-Ren Lu

Volume 19, Issue 1, 2019

Page: [15 - 23] Pages: 9

DOI: 10.2174/1871524919666190115130655

Abstract

The article entitled “Human Suicide, Modern Diagnosis Assistance and Magic Bullet Discovery”, by Da-Yong Lu, Peng-
Peng Zhu, Hong-Ying Wu, Nagendra Sastry Yarla, Bin Xu, Jian Ding, Ajit Varki and Ting-Ren Lu, has been retracted on the
request of the co-authors, Dr. Ajit Varki, Dr. Nagendra Sastry Yarla and Dr. Jian Ding available at: Cent Nerv Syst Agents Med
Chem 2019; 19(1): 15-23. http://www.eurekaselect.com/169003/article.


The Corresponding Author Dr. Da-Yong Lu has included the names of the co-authors, Dr. Ajit Varki, Dr. Nagendra Sastry
Yarla and Dr. Jian Ding without their consent and the manuscript has been published in the journal, Central Nervous System
Agents in Medicinal Chemistry (CNSAMC). Kindly see Bentham Science Policy on Article retraction at the link given below:


(https://benthamscience.com/journals/central-nervous-system-agents-in-medicinal-chemistry/author-guidelines/)


Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the
Copyright Letter or the Terms and Conditions. As such, this article represents a severe abuse of the scientific publishing system.
Bentham Science Publishers takes a very strong view on this matter and apologizes to the readers of the journal for any
inconvenience this may cause.

« Previous Next »
[1]
Lu, D.Y. Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed.; Da-Yong Lu, Nova Science Publishers, 2017, New York, US (ISBN-978-1-53610-601-5).
[2]
Lu, D.Y.; Lu, T.R.; Lu, Y.; Cao, S. Introduction for suicide study. J. Metab. Syndr., 2017, 6(2), 227.
[3]
Lu, D.Y.; Wu, H.Y.; Cao, S.; Lu, Y.; Yarla, N.S.; Che, J.Y. Historical analysis of suicide/mental disorder and current diagnostics in clinics., In: Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed.; Da-Yong Lu, Nova Science Publishers, 2017; New York: USA, Chapter 1, pp. 1-12.
[4]
Basta, M.; Vgontzas, A.; Kastanaki, A.; Michalodimitrakis, M.; Kanaki, K.; Koutr, K.; Anastasaki, M.; Simos, P. “Suicide rates in Crete, Greece” during the economic crisis: The effect of age, gender, unemployment and mental health service provision. BMC Psychiatry, 2018, 18, 356.
[5]
Acheampong, A.K.; Aziato, L. Suicidal ideations and coping strategies of moters livig with physical diabilities: A qualitative exploratory study in Ghana. BMC Psychiatry, 2018, 18, 360.
[6]
Lu, D.Y.; Zhu, P.P.; Wu, H.Y.; Yarla, N.S.; Xu, B.; Lu, T.R. Human suicide risk and treatment study. Cent. Nerv. Syst. Agents Med. Chem., 2018, 18(3), 206-212.
[7]
Lu, D.Y.; Lu, T.R.; Che, J.Y.; Zhu, P.P. Genetics and bioinformatics studies of antidepressant drug therapeutic efficacies and toxicities, a current overview. Recent Patents CNS Drug Discov., 2014, 9(3), 193-199.
[8]
Lu, D.Y.; Lu, T.R.; Zhu, P.P.; Che, J.Y. Genetics and bioinformatics study of antidepressant drugs, recent advancements and future trends.Suicidal Ideation: Predictors, Prevalence and Prevention; Weaver, B., Ed.; USA, 2015, pp. 57-71.
[9]
Lu, D.Y.; Lu, T.R.; Zhu, P.P.; Yarla, N.S.; Wu, H.Y. Current suicide prediction, prevention and treatments.Lu, D.Y; Risks, S.; Treatments, N.I.; Perspectives, F., Eds.; Nova Science Publishers: New York, USA, 2017, pp. 25-38.
[10]
Serafini, G.; Salano, P.; Amore, M. Suicidal ideation: A comprehensive overview.Suicidal Ideation: Predictors, Prevalence and Prevention; Weaver, B., Ed.; Nova Science Publishing: USA, 2015, pp. 1-42.
[11]
While, D.; Bickley, H.; Roscoe, A.; Windfuhr, K.; Rahman, S.; Show, J.; Appleby, L.; Kapur, N. Implementation of mental health service recommendations in England and Wales and suicide rates, 1997-2006: A cross-sectional and before-and-after observational study. Lancet, 2012, 379, 1005-1012.
[12]
Lu, D.Y.; Zhu, P.P.; Wu, H.Y.; Yarla, N.S.; Zhu, H.; Che, J.Y. Human suicide study, is there an associations between suicide and mental illness. Metabolomics, 2016, 6(3), 186.
[13]
Yuan, Q.; Seow, E.; Ablin, E.; Chua, B.Y.; Ong, H.L.; Samari, E.; Chong, S.A.; Subramaniam, M. Direct and moderating effects of personality on stigma towards mental illness. BM Psychiatry, 2018, 18, 358.
[14]
Kohyama, J. Serotonin is a key neurotransmitter in suicide., In: Encyclopedia of Suicide. Ed.; Torres, O.B. Nova Science Publishing; USA, Vol. 3, Chapter 9, 105-114, 2018.
[15]
Kapur, N.; Gask, L. Introduction to suicide and self-harm. Psychiatry, 2009, 8(7), 233-236.
[16]
Lu, D.Y.; Lu, T.R.; Zhu, P.P.; Wu, H.Y. The hypotheses for the pathogen of antimicrobial-induced mania and suicide., In: Encyclopedia of Suicide. Ed.; Torres, O.B. Nova Science Publishing, USA, Vol 3, Chapter 8, 97-104, 2018.
[17]
Kleefeld, F. HCV-associated neurological disorders. Intern. Med. Rev., 2017, 3(9), 1-9.
[18]
Bagalman, E. Suicide prevention efforts of the veteran health administration., In: Encyclopedia of Suicide. Ed.; Torres, O.B. Nova Science Publishing; USA, Vol. 3, Chapter 31, 603-622, 2018.
[19]
Cornelius, J.R.; Walker, J.D.; Klima, G.; Fisher, B. Suicidal symptoms among veterans with chronic PTSD evaluated for treatment at a VA hospital., In: Suicidal Ideation: Predictors, Prevalence and Prevention. Ed.; Weaver, B. Nova Science Publishing; USA, 2015, Chapter 2, pp. 43-56.
[20]
Lu, D.Y.; Lu, T.R.; Zhu, P.P.; Cao, S. Different ranges of outside factors upon human suicidal rates and mortalities., In: Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed.; Da- Yong Lu, Nova Science Publishers, New York, USA. Chapter 2, pp13-24, 2017.
[21]
Lu, D.Y.; Lu, T.R.; Zhu, P.P.; Che, J.Y. The efficacies and toxicities of antidepressant drugs in clinics, building the relationship between Chemo-Genetics and Socio-Environments. Cent. Nerv. Syst. Agents Med. Chem., 2016, 16(1), 12-18.
[22]
Lucas, G. Fast-acting antidepressants: Are we nearly there. Expert Rev. Neurother., 2008, 8(1), 1-3.
[23]
Menchetti, M.; Bortolotti, B.; Rucci, P.; Scocco, P.; Bombi, A.; Berardi, D. Depression in primary care: Interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS study. A multicenter randomized controlled trial. Rationale and design. BMC Psychiatry, 2010, 10, 97.
[24]
Menchetti, M.; Rucci, P.; Bortolotti, B.; Bombi, A.; Scocco, P.; Kraemer, H.C.; Berardi, D. Moderators of remission with interpersonal counseling or drug treatment in primary care patients with depression: Randomized controlled trial. Br. J. Psychiatry, 2014, 204(2), 144-150.
[25]
Haddad, M.; Walters, P.; Tylee, A. Mood disorders in primary care. Psychiatry, 2009, 8(2), 71-75.
[26]
McAllister-Williams, R.; Ferrier, I.N. Pharmacological management of unipolar affective disorder. Psychiatry, 2009, 8(4), 113-119.
[27]
McAllister-Williams, R.; Ferrier, I.N. Pharmacological management of bipolar affective disorder. Psychiatry, 2009, 8(6), 120-124.
[28]
Lu, D.Y.; Lu, T.R.; Ding, J.; Wu, H.Y.; Yarla, N.S.; Xu, B.; Lu, Y. Therapeutic drug developments and clinical utilities., In: Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed.; Lu,D.Y., Nova Science Publishers, New York: USA 2017; Chapter 6, pp. 63-72.
[29]
Lu, D.Y.; Lu, T.R.; Yarla, N.S.; Wu, H.Y. Genetics in suicide treatments, modern diagnosis establishments. J. Mental Disord. Treat, 2017, 3(2), 145.
[30]
Krystal, J.H.; State, M.W. Psychiatric disorders: Diagnosis to therapy. Cell, 2014, 157, 201-214.
[31]
Bondy, B.; Buettner, A.; Zill, P. Genetics of suicide. Mol. Psychiatry, 2006, 11, 336-351.
[32]
Malhotra, D.; Sebat, J. CNVs: Harbingers of a rare variant revolution in psychiatric genetics. Cell, 2012, 148, 1223-1241.
[33]
Frangou, S. Brain structural changes in mood disorders. Psychiatry, 2009, 8(3), 105-106.
[34]
Roiser, J.P.; Rubinsztein, J.S.; Sahakian, B.J. Neuropsychology of affective disorders. Psychiatry, 2009, 8(3), 91-96.
[35]
Frangou, S. Functional neuroimaging in mood disorder. Psychiatry, 2008, 6(3), 102-104.
[36]
Read, J.; Runciman, O.; Dillon, J. In search of an evidence-based role for psychiatry. FSOA. 2016, 2(1), fsoa-2015-0011.
[37]
Desmyter, S.; Bijttebier, S.; Heeringen, K.V. The role of neuroimaging in our understanding of the suicidal brain. CNS Neurol. Disord. Drug Targets, 2013, 12(7), 921-929.
[38]
Sueki, H. Suicide prevention using the Internet; mini-review and case study in online gate-keeping activity, In: Suicidal Ideation: Predictors, Prevalence and Prevention. Ed.; Weaver, B., Nova Science Publishing; USA, Chapter 5, pp. 85-100, 2015.
[39]
Morriss, R. Psychological models of mood disorders. Psychiatry, 2009, 8(3), 82-86.
[40]
Kerfoot, M. Managing suicidal behavior in adolescents. Psychiatry, 2009, 8(7), 252-256.
[41]
Lu, D.Y.; Zhu, P.P.; Lu, T.R.; Che, J.Y. The suicidal risks and treatments, seek medications from multi-disciplinary. Cent. Nerv. Syst. Agents Med. Chem., 2016, 16(3), 231-239.
[42]
Lu, D.Y.; Zhu, P.P.; Wu, H.Y.; Lu, Y.; Che, J.Y. New modes of suicide/mental disorder diagnostics and therapeutics., In: Suicide Risks and Treatments, New Ideas and Future Perspectives. Ed.; Lu, D.Y., Nova Science Publishers, New York, USA; Chapter 5, pp. 51-62, 2017.
[43]
Jin, R.; Chen, F.P.; Zhu, J.F.; Gao, Z.H.; Shen, Y.; Chen, Z.Y.; Ren, Z.B.; Ma, Y.C.; Jin, W.D. Lithium carbonate and lamotrigine for treatment of bipolar depression: Which is better? Results from Chinese data in meta-analysis. EC Psychol. Psychiatry, 2018, 7(12), 992-1002.
[44]
Ahuja, V. New drug approvals by FDA from 2013-2017. EC Pharmacol. Toxicol, 2018, 6(9), 772-774.
[45]
Rubino, A.; Roskell, N.; Tennis, P.; Mines, D.; Weich, S.; Andrews, E. Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: Retrospective cohort study. BMJ, 2007, 334(7587), 242-247.
[46]
Kovacs, D.; Gonda, X.; Petschner, P.; Edes, A.; Eszlari, N.; Bagdy, G.; Juhasz, G. Antidepressant treatment response is modulated by genetic and environmental factors and their interactions. Ann. Gen. Psychiatry, 2014, 13(1), 17.
[47]
Teicher, M.H.; Glod, C.; Cole, J.O. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am. J. Psychiatry, 1990, 147, 207-210.
[48]
Tsai, S.J. Possible involvement of the BDNF-dependent pathway in the treatment-emergent suicidality or decreased response to antidepressants. Med. Hypotheses, 2005, 65(5), 942-946.
[49]
Lu, D.Y.; Lu, T.R.; Ding, J. May genetic factors play a role in the risk of antidepressant-induced suicide. Med. Hypotheses, 2007, 69(6), 1380-1381.
[50]
Lu, D.Y.; Lu, T.R.; Zhu, P.P. Undesired neural side-effects of a drug, a chemical and genetic interrelated problem. Cent. Nerv. Syst. Agents Med. Chem., 2010, 10(2), 108-112.
[51]
Lu, D.Y.; Lu, T.R. Importance of genomic studies for drug withdrawal with mental illness. Drug Ther. Studies, 2011, 1(1), e11.
[52]
Brent, D.; Melhem, N.; Turecki, G. Pharmacogenomics of suicidal events. Pharmacogenomics, 2010, 11(6), 793-807.
[53]
Kendell, R. Diagnosis and classification of mood disorders. Psychiatry, 2006, 5(4), 112-114.
[54]
Lu, D.Y.; Lu, T.R.; Zhu, P.P. How can we pinpoint genetic involvement in antidepressant-induced suicide? Adv. Pharmacoepidemiol. Drug Saf., 2012, 1(1), e101.
[55]
Lu, D.Y.; Lu, T.R.; Zhu, P.P. Genetics in neural toxicities of drugs. Cent. Nerv. Syst. Agents Med. Chem., 2012, 12(4), 250-253.
[56]
Zhao, Y.; Xiong, N.; Liu, Y.; Zhou, Y.H.; Li, N.M.; Qing, H.; Lin, Z.C. Human dopamine transporter gene: Differential regulation of 18-kb haplotypes. Pharmacogenomics, 2013, 14(12), 1481-1494.
[57]
Youngtrom, I.A.; Strowbridge, B.W. Visual landmarks facilitate rodent, spatial navigation in virtual reality environment. Learn. Mem., 2012, 9(3), 84-90.
[58]
Lu, D.Y.; Lu, T.R.; Zhu, P.P. Pharmacogenetics in neural toxicities of drugs. Pharmacogenomics, 2013, 14(10), 1129-1131.
[59]
de Castro, A.; Concheiro, M.; Quintela, O.; Cruz, A.; Lopez-Rivadulla, M. LC-MS/MS method for the determination of nine antidepressants and some of their main metabolites in oral fluid and plasma: Study of correlation between venlafaxine concentrations in both matrices. J. Pharm. Biomed. Anal., 2008, 48, 183-193.
[60]
Palego, L.; Giannaccini, G.; Masala, I.; Pacciardi, B.; Palagini, L.; Luchini, F.; Belli, S.; Lucacchini, A.; Mauri, M.; Betti, L. Analysis of trazodone and m-CPP in human serum by RPLC and UV-photodiode assay detection. J. Basic Appl. Res. Intl, 2016, 12(2), 85-95.
[61]
Lu, D.Y.; Lu, T.R.; Yarla, N.S. Human suicide study from mathematical approaches. Clin. Biotechnol. Microbiol, 2018, 2(3), 361-363.
[62]
Lu, D.Y.; Lu, T.R.; Lu, Y.; Wu, H.Y.; Yarla, N.S. The acquisition of mathematical language in biomedical articles. J. Cell Dev. Biol., 2017, 1(1), 8.
[63]
Gentle, J.E. Elements of Computational Statistics. Springer Science, Germany, 2002 (ISBN 7-03-016686-8).
[64]
Hsu, G.C. Using math-physical medicine to study the risk probability of having heart attack or stroke based on 3 approaches, medical condition, lifestyle management details and metasbolic index. EC Cardiol, 2018, 5(12), 925-933.
[65]
Joaquim, R.M.; de Olivera, F.C.S.; Fajardo, R.S.; Caramaschi, S. Psychobiology of sadness: Functional aspects in human evolution. EC Psychol. Psychiatry, 2018, 7(12), 1015-1022.
[66]
Majid, U.; Ennis, J. The role of meaning in life in adjustment to a chronic medical condition, A review. EC Psychol Psychiatry, 2018, 7(12), 1023-1030.
[67]
Molinaro, M. Psychotherapy, the dance between art and science. EC Psychol Psychiatry, 2018, 7(12), 1003-1004.
[68]
Cao, S.; Lu, D.Y.; Lu, T.R.; Yarla, N.S. Future directions in the field of suicide study. EC Orthopaed, 2017, 6(6), 206-208.

Rights & Permissions Print Cite
Article Metrics
64
11
© 2024 Bentham Science Publishers | Privacy Policy